Apple Analyst Sees $760 Ahead and 3 Stock Insights to Eye
Joy Global, Inc (NYSE:JOY) risk/reward is seen by Barclays as being favorable, especially when considering solid earnings visibility and possible aftermarket growth. Shares have an Overweight rating and a $81 price target.
Sarepta Therapeutics (NASDAQ:SRPT): At the World Muscle Society Congress, Dr. Jerry Mendell presented the Phase IIb data for Sarepta’s Eteplirsen over the weekend, and Piper Jaffray claims that the Duchenne Muscular Dystrophy treatment is active. The firm sees a possibility for accelerated approval, and it keeps its Overweight rating and a $38 price target on the stock.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>
Apple Inc. (NASDAQ:AAPL): According to Pacific Crest, concerns regarding the iPhone 5 may be overdone, and the firm still expects that the company will sell 51 million iPhones during its December quarter. The firm keeps its Outperform rating and a $760 target on the stock.
SanDisk Corp. (NASDAQ:SNDK) results are expected by Pacific Crest to see a surge due to improved NAND pricing. The firm thinks that the company has the ability to provide a “slight” beat and raise, and it still recommends purchasing the stock.
Don’t Miss: No Room For Love Between Apple and Samsung.